An Emerging Consensus on Grading Recommendations?_Chinese Journal of Evidence-Based Medicine

Authors：

Gordon Guyatt MSc

*Department of Medicine, McMaster University, Hamilton, Ontario, Canada§§Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada;

Corresponding author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Gordon Guyatt MSc,M,D. An Emerging Consensus on Grading Recommendations?. Chinese Journal of Evidence-Based Medicine, 2007, 07(1): 1-8. doi: Copy

1.	Schunemann HJ, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Cmaj, 2003, 169(7): p. 677–680.
2.	Atkins D, et al. Grading quality of evidence and strength of recommendations. Bmj, 2004, 328(7454): p. 1490.
3.	Guyatt G, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest, 2006, 129(1): p. 174–181.
4.	Schunemann HJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med, 2006, 174(5): p. 605–614.
5.	Warkentin TE and A. Greinacher, Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 311S–337S.
6.	Clagett GP, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 609S–626S.
7.	Bhandari M, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Cmaj, 2004, 170(4): p. 477–480.
8.	Alonso-Coello P, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg, 2006, 93(8): p. 909–920.
9.	Devereaux PJ, et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. Cmaj, 2002, 166(11): p. 1399–1406.
10.	Charles C., T. Whelan, and A. Gafni, What do we mean by partnership in making decisions about treatment? Bmj, 1999, 319(7212): p. 780–782.
11.	van Walraven, C., et al., Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. Jama, 2002, 288(19): p. 2441–2448.
12.	Devereaux, P.A., DR. Gardner, MJ. Putnam, W. Flowerdew, GJ. Brownell, BF. Nagpal, S. Cox, JL., Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Bmj, 2001, 323(7323): p. 1218–1222.
13.	CAPRIE-Steering-Committee, A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet, 1996. 348: p. 1329–1339.

1. Schunemann HJ, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Cmaj, 2003, 169(7): p. 677–680.
2. Atkins D, et al. Grading quality of evidence and strength of recommendations. Bmj, 2004, 328(7454): p. 1490.
3. Guyatt G, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest, 2006, 129(1): p. 174–181.
4. Schunemann HJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med, 2006, 174(5): p. 605–614.
5. Warkentin TE and A. Greinacher, Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 311S–337S.
6. Clagett GP, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 609S–626S.
7. Bhandari M, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Cmaj, 2004, 170(4): p. 477–480.
8. Alonso-Coello P, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg, 2006, 93(8): p. 909–920.
9. Devereaux PJ, et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. Cmaj, 2002, 166(11): p. 1399–1406.
10. Charles C., T. Whelan, and A. Gafni, What do we mean by partnership in making decisions about treatment? Bmj, 1999, 319(7212): p. 780–782.
11. van Walraven, C., et al., Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. Jama, 2002, 288(19): p. 2441–2448.
12. Devereaux, P.A., DR. Gardner, MJ. Putnam, W. Flowerdew, GJ. Brownell, BF. Nagpal, S. Cox, JL., Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Bmj, 2001, 323(7323): p. 1218–1222.
13. CAPRIE-Steering-Committee, A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet, 1996. 348: p. 1329–1339.

Chinese Journal of Evidence-Based Medicine

An Emerging Consensus on Grading Recommendations?

Abstract Full text Figures/Tables Video References Cited by

Format

Content